Journal of Medicinal Chemistry · 2002 · 153 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionLigand BindingLigand-based DesignPotency OptimizationStructure-activity Relationship AnalysisSulfur ChemistryCarbonic Anhydrase InhibitorsEnzyme Inhibitor DiscoveryIsozyme SelectivityLigand Binding AffinityLigand Binding Engineering
X-ray crystal structures of the adducts of human carbonic anhydrase (hCA) isozyme II with derivatives incorporating a sulfamide or sulfamic acid moiety are reported. The absence of a C-SO(2)NH(2) bond in the first type of compound can be exploited for the design of more potent and selective CA inhibitors. This study also explains why sulfate is a several-orders-of-magnitude weaker CA inhibitor compared to derivatives incorporating sulfonamide/sulfamide moieties.
15
Sulphanilamide as a Specific Inhibitor of Carbonic Anhydrase
Fabrizio Briganti, Roberta Pierattelli, Andrea Scozzafava · European Journal of Medicinal Chemistry · 1996 · 156 citations
Pharmacy, Biochemistry, Chemistry +17